Display options
Cite
Sendor AB, Hacker KE, Chen S, et al. Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss. Gastrointest Cancer. 2015;5:61-71doi: 10.2147/GICTT.S72274.
Sendor, A. B., Hacker, K. E., Chen, S., Corona, A. L., Sen, O., Chiang, D. Y., Snavely, A., Rogers, A. B., Montgomery, S. A., Rathmell, W. K., & McRee, A. J. (2015). Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss. Gastrointestinal cancer : targets and therapy, 561-71. https://doi.org/10.2147/GICTT.S72274
Sendor, Adam B, et al. "Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss." Gastrointestinal cancer : targets and therapy vol. 5 (2015): 61-71. doi: https://doi.org/10.2147/GICTT.S72274
Sendor AB, Hacker KE, Chen S, Corona AL, Sen O, Chiang DY, Snavely A, Rogers AB, Montgomery SA, Rathmell WK, McRee AJ. Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss. Gastrointest Cancer. 2015 Feb 01;5:61-71. doi: 10.2147/GICTT.S72274. PMID: 25844041; PMCID: PMC4383253.
Copy Download .nbib Format: NLM
Share it on

Gastrointest Cancer. 2015 Feb 01;5:61-71. doi: 10.2147/GICTT.S72274.

Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss.

Gastrointestinal cancer : targets and therapy

Adam B Sendor, Kathryn E Hacker, Shufen Chen, Armando L Corona, Oishee Sen, Derek Y Chiang, Anna Snavely, Arlin B Rogers, Stephanie A Montgomery, W Kimryn Rathmell, Autumn J McRee

Affiliations

  1. Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
  2. Section of Pathology, Department of Biomedical Sciences, Cummings School of Veterinary Medicine, Tufts University, Boston, MA, USA.

PMID: 25844041 PMCID: PMC4383253 DOI: 10.2147/GICTT.S72274

[No abstract available.]

Keywords: Von Hippel-Lindau (VHL); cholangiocarcinoma (CC); hepatocellular-cholangiocarcinoma (HCC); phosphatase and tension homologue deleted on chromosome 10 (PTEN)

References

  1. Int J Clin Oncol. 2010 Feb;15(1):59-64 - PubMed
  2. Clin Cancer Res. 2009 Jan 15;15(2):660-7 - PubMed
  3. Pancreas. 2008 Apr;36(3):e1-9 - PubMed
  4. CA Cancer J Clin. 2012 Jul-Aug;62(4):220-41 - PubMed
  5. J Clin Invest. 2006 Jul;116(7):1843-52 - PubMed
  6. PLoS Biol. 2003 Dec;1(3):E59 - PubMed
  7. J Hepatol. 2004 Aug;41(2):292-8 - PubMed
  8. World J Gastroenterol. 2005 Aug 14;11(30):4644-9 - PubMed
  9. Angiogenesis. 2010 Mar;13(1):59-69 - PubMed
  10. Proc Natl Acad Sci U S A. 2001 Feb 13;98 (4):1583-8 - PubMed
  11. Hepat Mon. 2012 Oct;12(10 HCC):e7492 - PubMed
  12. Nat Rev Cancer. 2002 Jul;2(7):489-501 - PubMed
  13. Diabetes. 2007 Nov;56(11):2759-65 - PubMed
  14. Mol Cell Biol. 2003 Sep;23 (17 ):6139-49 - PubMed
  15. Mol Cell Biochem. 2013 Jul;379(1-2):191-9 - PubMed
  16. J Cell Biochem. 2014 Jun;115(6):1147-58 - PubMed
  17. J Hepatol. 2014 Jan;60(1):224-6 - PubMed
  18. Tumour Biol. 2013 Dec;34(6):3637-48 - PubMed
  19. Hepatogastroenterology. 2011 Sep-Oct;58(110-111):1439-44 - PubMed
  20. Tumour Biol. 2014 May;35(5):4095-9 - PubMed
  21. Nat Rev Cancer. 2003 Oct;3(10):721-32 - PubMed
  22. J Gastroenterol Hepatol. 2006 Nov;21(11):1744-51 - PubMed
  23. Hepatology. 2014 Dec;60(6):1972-82 - PubMed
  24. Clin Cancer Res. 2007 Aug 15;13(16):4795-9 - PubMed
  25. Cancer Cell. 2008 Dec 9;14 (6):435-46 - PubMed
  26. Physiol Genomics. 2009 May 13;37(3):187-98 - PubMed
  27. Cancer Discov. 2011 Aug;1(3):222-35 - PubMed
  28. Cancer Res. 2010 Apr 15;70(8):3034-41 - PubMed
  29. Patholog Res Int. 2011 Apr 07;2011:403929 - PubMed
  30. Hepatology. 2008 Dec;48(6):1799-809 - PubMed
  31. J Lipid Res. 2011 Apr;52(4):593-617 - PubMed
  32. J Hepatol. 2012 Feb;56(2):441-7 - PubMed
  33. Genesis. 2003 Feb;35(2):100-6 - PubMed
  34. Lab Invest. 2006 Feb;86(2):154-65 - PubMed
  35. Cancer Cell. 2003 Jan;3(1):75-88 - PubMed
  36. Nat Genet. 2013 Dec;45(12 ):1474-8 - PubMed

Publication Types

Grant support